Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational ...
INTASYL Compound RXI-231: a promising approach to treatment of hyperpigmentation Marlborough, Massachusetts--(Newsfile Corp. ...
WhatsYourTech6 天
High-Tech Tables Blur the Lines Between Real and Virtual, Medicine and Gaming, Teaching and ...
He’s a digital cadaver, a detailed medical visualization. And the sophisticated technology underlying the high-tech table on ...
Pharmaceutical Technology3 天
Pembrolizumab by Merck for Anal Cancer: Likelihood of Approval
Pembrolizumab is under clinical development by Merck and currently in Phase II for Anal Cancer. According to GlobalData, Phase II drugs for Anal Cancer have a 19% phase transition success rate (PTSR) ...
Pharmaceutical Technology3 天
Pembrolizumab by Merck for Metastatic Breast Cancer: Likelihood of Approval
Pembrolizumab is under clinical development by Merck and currently in Phase II for Metastatic Breast Cancer. According to GlobalData, Phase II drugs for Metastatic Breast Cancer have a 32% phase ...